Insider Transactions last 24 months for Enliven Therapeutics, Inc.  -  NSDQ: ELVN

 
Transactions
All Buy Sell Option Exercise
Filer's Name
Relationship/
Title
Trans.
Date
Trans. Type
Ownership Type
Security Type
Shares
Price
Trans.
Value
Total Shares Owned
Lyssikatos Joseph PCHIEF SCIENTIFIC OFFICER09/23/2025DSIndirectCOM1,500$20.03$30,045.00931,688
Kintz SamuelPRESIDENT AND CEO09/23/2025DSIndirectCOM2,800$20.03$56,084.00919,092
Lyssikatos Joseph PCHIEF SCIENTIFIC OFFICER09/19/2025DSIndirectCOM2,130$20.02$42,634.08933,188
Lyssikatos Joseph PCHIEF SCIENTIFIC OFFICER09/19/2025DSIndirectCOM4,870$19.11$93,063.27935,318
Kintz SamuelPRESIDENT AND CEO09/19/2025DSIndirectCOM1,000$20.25$20,250.00921,892
Kintz SamuelPRESIDENT AND CEO09/17/2025DSIndirectCOM5,000$19.09$95,473.00922,892
Patel AnishCHIEF OPERATING OFFICER09/08/2025DSIndirectCOM6,667$20.24$134,957.41283,308
Hohl BenjaminCHIEF FINANCIAL OFFICER08/27/2025DSDirectCOM3,250$20.63$67,038.7323,000
Hohl BenjaminCHIEF FINANCIAL OFFICER08/27/2025AMDirectCOM3,250$2.48$8,060.0026,250
Lyssikatos Joseph PCHIEF SCIENTIFIC OFFICER08/21/2025DSIndirectCOM7,500$20.01$150,099.00940,188
Kintz SamuelPRESIDENT AND CEO08/19/2025DSIndirectCOM590$20.00$11,800.00929,409
Lyssikatos Joseph PCHIEF SCIENTIFIC OFFICER08/19/2025DSIndirectCOM5,000$19.62$98,117.50947,688
Kintz SamuelPRESIDENT AND CEO08/18/2025DSIndirectCOM10,393$20.02$208,106.31929,999
Patel AnishCHIEF OPERATING OFFICER08/07/2025DSIndirectCOM405$18.93$7,666.53289,975
Patel AnishCHIEF OPERATING OFFICER08/07/2025DSIndirectCOM6,262$18.20$113,948.99290,380
Hohl BenjaminCHIEF FINANCIAL OFFICER07/28/2025DSDirectCOM65$21.30$1,384.5223,000
Hohl BenjaminCHIEF FINANCIAL OFFICER07/28/2025DSDirectCOM3,185$20.45$65,119.2423,065
Hohl BenjaminCHIEF FINANCIAL OFFICER07/28/2025AMDirectCOM3,250$2.48$8,060.0026,250
Lyssikatos Joseph PCHIEF SCIENTIFIC OFFICER07/21/2025DSIndirectCOM576$22.90$13,187.75952,688
Lyssikatos Joseph PCHIEF SCIENTIFIC OFFICER07/21/2025DSIndirectCOM11,924$22.26$265,458.05953,264
Kintz SamuelPRESIDENT AND CEO07/17/2025DSIndirectCOM3,663$23.37$85,606.51940,392
Kintz SamuelPRESIDENT AND CEO07/17/2025DSIndirectCOM4,687$22.69$106,359.75944,055
Kintz SamuelPRESIDENT AND CEO07/17/2025DSIndirectCOM4,150$21.58$89,551.61948,742
Hohl BenjaminCHIEF FINANCIAL OFFICER07/10/2025DSDirectCOM1,000$22.66$22,655.0023,000
Hohl BenjaminCHIEF FINANCIAL OFFICER07/10/2025AMDirectCOM1,000$2.48$2,480.0024,000
1   2  3  4  5  6  7  8  9  10  Next Last  You are at page 1 of 12 pages
Transaction Type Key
First letter: A = Acquired, D = Disposed
Second letter:
A = Grant, award or other acquisition pursuant to Rule 16b-3(d) C = Conversion of derivative security | D = Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e) | E = Expiration of short derivative position | F = Payment of exercise price or tax liability by delivering or withholding securities incident to the receipt, exercise or vesting of a security issued in accordance with Rule 16b-3. | G = Gift | H = Expiration (or cancellation) of long derivative position with value received | I = Discretionary transaction in accordance with Rule 16b-3(f) | J = Other | L = Small acquisition under Rule 16a-6 | M = Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | O = Exercise of out-of-the-money derivative security | P = Open market or private purchase | S = Open market or private sale | U = Disposition pursuant to a tender of shares in a change of control transaction | W = Acquisition or disposition by will or the laws of descent and distribution | X = Exercise of in-the-money or at-the-money derivative security | Z = Deposit into or withdrawal from voting trust 		Export Table Data to Excel Send to Excel